E34.322
✓ Billable
Insulin-like growth factor-1 (IGF-1) resistance
ICD-10-CM · FY2026 · Endocrine, Nutritional and Metabolic Diseases
Code
E34.322
System
ICD-10-CM
Billable
Yes — valid for submission
Effective
FY2026
Chapter
Endocrine, Nutritional and Metabolic Diseases
Source
CMS / CDC NCHS
⚠ Verify before billing. Confirm against the current CMS/NCHS ICD-10-CM files and your payer's rules before claims submission.
Frequently asked questions
What is ICD-10 code E34.322?
ICD-10-CM code E34.322 represents Insulin-like growth factor-1 (IGF-1) resistance. It is a billable diagnosis code in the Endocrine, Nutritional and Metabolic Diseases chapter, effective October 1, 2025 – September 30, 2026.
Is E34.322 billable?
Yes. E34.322 is a valid billable ICD-10-CM code for insurance claims and clinical documentation.
What chapter is E34.322 in?
E34.322 belongs to the Endocrine, Nutritional and Metabolic Diseases chapter (E00–E89) of ICD-10-CM.
Related codes in the E34 category
E34
Other endocrine disorders
Non-billable
E34.0
Carcinoid syndrome
Non-billable
E34.1
Other hypersecretion of intestinal hormones
Billable
E34.2
Ectopic hormone secretion, not elsewhere classified
Billable
E34.3
Short stature due to endocrine disorder
Non-billable
E34.4
Constitutional tall stature
Billable
E34.5
Androgen insensitivity syndrome
Non-billable
E34.8
Other specified endocrine disorders
Billable
Search all 98,186 ICD-10-CM codes instantly
Search ICDwise →